Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? Authors' response.

导出 OA

翻译打印收藏纠错

作者： Alexander,Supady ^[1] ; Daniel,Duerschmied ^[2]

作者单位： Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Germany; Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Germany; Heidelberg Institute of Global Health, University of Heidelberg, Germany. Electronic address: alexander.supady@uniklinik-freiburg.de. ^[1] Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Germany; Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Germany. ^[2]

关键词 COVID-19 Coronavirus Cytokines Extracorporeal membrane oxygenation Hemoadsorption Interleukin-6

主题词体外膜氧合作用(Extracorporeal Membrane Oxygenation);血液灌注(Hemoperfusion);人类(Humans)

DOI 10.1016/j.jcrc.2021.08.003

PMID 34418636

发布时间 2022-12-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交